TY  - JOUR
AU  - Llaneras, Jordi
AU  - Fernández Vázquez, María Inmaculada
AU  - Buti, Maria
PY  - 2019
DO  - 10.1016/j.jhep.2019.06.002
UR  - https://hdl.handle.net/20.500.14352/129575
T2  - Journal of Hepatology
AB  - Background & aims: Around 5% of patients with chronic hepatitis C virus (HCV) infection treated with direct-acting antiviral (DAA) agents do not achieve sustained virological response (SVR). The currently approved retreatment regimen for prior DAA...
LA  - eng
M2  - 666
PB  - Elsevier
KW  - HCV genotype 3
KW  - Hepatitis C
KW  - Sofosbuvir
KW  - Treatment failures
KW  - Velpatasvir
KW  - Voxilaprevir
TI  - Effectiveness and Safety of Sofosbuvir/Velpatasvir/ Voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs
TY  - journal article
VL  - 71
ER  -